RLMD
Relmada TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
RSI (14)
47.7
Neutral
MACD Hist
0.06
Bullish
ATR (14)
0.18
Available
Vol Z (20)
0.01
Normal
RET 20D
-4.4%
Negative
Dist 52W High
-56.2%
Below High
Technical chart
1 YearCandles, moving averages, and volume using the current RankAlpha theme.
As of 2026-10-29
Price
SMA 20
SMA 50
SMA 200
Trend readout
Technical readout
Trend
Downtrend (SMA20 < SMA50 < SMA200)
Momentum
Negative momentum · 20D -4.4% · 60D -35.9%
RSI / MACD
RSI 47.7 (Neutral) · MACD hist +0.06
Volatility
Volatility normal (Z 0.01)
SMA20
3.31
SMA50
3.86
SMA200
5.36
EMA12
3.32
EMA26
3.48
BB Upper
3.56
BB Mid
3.31
BB Lower
3.05
RET 5D
+5.2%
RET 20D
-4.4%
RET 60D
-35.9%
RET 120D
-53.3%
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data

